Norges Bank bought shares in Bristol-Myers Squibb (BMY), while TD Cowen and Raymond James Financial started coverage, and Truist Financial reiterated buy ratings.
2 reports, 2 independent
Updated Sep 8
Gone quiet
- Reports
- 2
- Developments
- 1
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Norges Bank bought shares in Bristol-Myers Squibb (BMY), while TD Cowen and Raymond James Financial started coverage, and Truist Financial reiterated buy ratings.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Bristol-Myers Squibb
American pharmaceutical company
-
Norges Bank
central bank of Norway
-
Geode Capital Management
American Investment Management firm based in Boston, Massachusetts
-
Raymond James Financial
American Investment Bank and Financial Services Firm
Related events
- Norges Bank bought a stake in Expeditors International, a company listed on Nasdaq and filing disclosures with the SEC.
- Raymond James Financial and TD Cowen issued rating updates for GDS, alongside an insider transaction disclosure filed with the SEC.
- Norges Bank purchased a new position in shares of Boston Scientific.
- Rating firms Raymond James Financial and TD Cowen provided reaffirmed buy ratings and price targets for a company listed on Nasdaq.
- Norges Bank bought a new position in shares of GE Aerospace, coinciding with Jefferies reiterating a buy rating on the company.